IBIO Adds Its Voice to Growing List of State Associations Providing Feedback to CMS on the Translational Coverage for Emerging Technologies Notice
September 01, 2023
September 01, 2023
CHICAGO, Illinois, Sept. 1 (TNSres) -- The Illinois Biotechnology Innovation Organization issued the following news:
iBIO has consistently advocated for a fast and efficient approach to Medicare coverage for groundbreaking medical devices and diagnostics that enhance patient outcomes in cases of severe or life-threatening illnesses. We commend CMS for revisiting this vital matter.
While the TCET notice represents a positive step forward, we strongly believe that much mo . . .
iBIO has consistently advocated for a fast and efficient approach to Medicare coverage for groundbreaking medical devices and diagnostics that enhance patient outcomes in cases of severe or life-threatening illnesses. We commend CMS for revisiting this vital matter.
While the TCET notice represents a positive step forward, we strongly believe that much mo . . .